No 04 2024
Updated: January 31, 2025, 09:21 am
Published: November 28, 2024
Updated: January 31, 2025, 09:21 am
Published: November 28, 2024
Top stories
In a new job – November 18, 2026
Sten Sörensen has resigned from the board of SynAct Pharma to focus on his executive responsibilities.
In a new job – November 18, 2026
Jeppe Øvlesen has resigned as chair and member of the board of Cereno Scientific at his own request, effective immediately, a day after board member Johan Eriksson also left the board.
Pharma Business – November 18, 2026
Biovica has received a second work order, worth about USD 150,000 (about SEK 1.4 million), from one of the world’s leading pharmaceutical companies under its recently expanded master services agreement.
Biotech Business – November 18, 2026
Lytix Biopharma has raised NOK 80 million in a private placement and retail offering to prepare a registrational Phase III study of ruxotemitide in neoadjuvant melanoma.
Related posts
This site uses cookies